✦ LIBER ✦

Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers

✍ Scribed by Malook S. Gujral; Pravas M. Patnaik; Rashmi Kaul; Hemen K. Parikh; Christian Conradt; Chetan P. Tamhankar

Book ID: 105994763
Publisher: Springer
Year: 2001
Tongue: English
Weight: 100 KB
Volume: 47
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800170005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiation therapy and lymphocyte respons

Radiation therapy and lymphocyte responses in patients with head and neck cancer

✍ V.K. Jenkins; M.H. Olson 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Management of radiation therapy-induced

Management of radiation therapy-induced mucositis in head and neck cancer patients. Part I: Clinical significance, pathophysiology and prevention

✍ Wei Cheong Ngeow; Wen Lin Chai; Rosnah Binti Zain 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 96 KB

Impact of anemia in patients with head a

Impact of anemia in patients with head and neck cancer treated with radiation therapy

✍ Kenneth Hu; Louis B. Harrison 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 501 KB

Radiation-induced xerostomia in patients

Radiation-induced xerostomia in patients with head and neck cancer : A literature review

✍ Piet Dirix; Sandra Nuyts; Walter Van den Bogaert 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

Management of radiation therapy-induced

Management of radiation therapy-induced mucositis in head and neck cancer patients. Part II: supportive treatments

✍ Wei Cheong Ngeow; Wen Lin Chai; Rosnah Binti Zain 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 151 KB

Concomitant radiation therapy and cis-di

Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer

✍ Creagan, Edward T. ;Fountain, Karen S. ;Frytak, Stephen ;Desanto, Lawrence W. ;E 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## Abstract Three patients with locally advanced head and neck squamous cell cancer received concomitant radiation therapy (XRT) and cis‐diamminedichloroplatinum (CDDP). The dose of 6,000 rads was to be administered in two 3,000‐rad courses separated by 3 weeks. The CDDP, 30 mg/m^2^, was to be give